中性喘 - - 从机制到治疗的新视角
Ilona Iwaszko1, Krzysztof Specjalski1, Marta Chełmińska1
1Department of Allergology, Medical University of Gdansk, 80-210 Gdansk, Poland.
Journal of clinical medicine
|October 29, 2025
概括
中性喘 (NA),一种严重的喘类型,涉及高中性细胞数量,并与较差的类固醇反应有关. 理解NA的理解NA的理解
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 中性喘 (NA) 是一种炎症性喘表型.
- 它的特点是中性粒细胞高 (>40-76%) 和低乙中性粒细胞 (<2%).
- 在成年喘人群中估计患病率为16-28% .
研究的目的:
- 审查NA的患病率,机制和临床特征.
- 讨论目前的治疗选择和NA管理的未来前景.
主要方法:
- 对中性友性喘现有文献的综述.
- 对诊断标准,临床特征和炎症途径的分析.
主要成果:
- 亚麻氏体出现晚期发作,频繁恶化,症状控制不良,类固醇疗效降低.
- 这是一种由Th1/Th17反应驱动的T2低的炎症.
- 中性粒细胞释放促炎性细胞因子和化学因子,使炎症延续.
结论:
- 由于其独特的病理生理学,NA需要不同的管理策略.
- 准Th1/Th17通路和中性粒细胞衍生媒介提供了有前途的治疗途径.
相关概念视频
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K


